Search
voltage-dependent Ca+2 channel alpha-1C (Ca+2 channel L type alpha-1 polypeptide isoform 1, cardiac muscle, Cav1.2, CACNA1C, CACNL1A1, CCHL1A1, CACH2, CACN2)
Dihydropyridine-sensitive, long-acting L-type Ca+2 currents
Function:
- pore-forming & voltage-sensitive alpha-1 subunit of voltage-sensitive Ca+2 channel
- alpha-1C gives rise to L-type Ca+2 currents;
a) long-lasting (L-type) Ca+2 channels belong to the 'high-voltage activated' (HVA) group
b) blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, & by omega-agatoxin-IIIA (omega-Aga-IIIA)
c) insensitive to omega-conotoxin-GVIA (omega-CTx-GVIA) & omega-agatoxin-IVA (omega-Aga-IVA)
- Ca+2 channels containing the alpha-1C subunit play a role in excitation-contraction coupling in the heart
- the various isoforms display marked differences in the sensitivity to dihydropyridines
- phosphorylation by PKA activates the channel (putative)
Structure:
- each of the 4 internal repeats contains 5 hydrophobic transmembrane segments (S1, S2, S3, S5, S6) & one positively charged transmembrane segment (S4)
- S4 segments probably represent the voltage-sensor; they are characterized by a series of positively charged amino acids at every third position
- binding of intracellular Ca+2 through the EF-hand motif inhibits the opening of the channel (putative)
- belongs to the Ca+2 channel alpha-1 subunit (TC 1.A.1.11) family
Compartment: membrane
Alternative splicing: named isoforms=35
Expression:
- expressed in brain, heart, jejunum, ovary, pancreatic beta-cells & vascular smooth muscle
Pathology:
- expression is reduced in atherosclerotic vascular smooth muscle
- defects in CACNA1C are the cause of
a) Timothy syndrome
b) Brugada syndrome type 3
- variations in CACNA1C may be associated with:
- autism, ADHD, bipolar disorder, depression, &/or schizophrenia [3] (abstract does not specify which)
Related
anti-Vgcc antibody
voltage-dependent Ca+2 channel
General
voltage-dependent Ca+2 channel alpha-1
Properties
SIZE: MW = 249 kD
entity length = 2221 aa
COMPARTMENT: cellular membrane
MOTIF: cytoplasmic domain {1-124}
transmembrane domain {125-143}
exoplasmic loop {144-160}
MOTIF: N-glycosylation site {N153}
transmembrane domain {161-181}
cytoplasmic loop {182-193}
transmembrane domain {194-212}
exoplasmic loop {213-232}
transmembrane domain {233-251}
cytoplasmic loop {252-270}
transmembrane domain {271-290}
exoplasmic loop {291-380}
MOTIF: N-glycosylation site {N328}
transmembrane domain {381-405}
cytoplasmic loop {406-524}
MOTIF: BINDING TO BETA SUBUNIT {428-445}
transmembrane domain {525-543}
exoplasmic loop {544-558}
transmembrane domain {559-578}
cytoplasmic loop {579-586}
transmembrane domain {587-605}
exoplasmic loop {606-615}
transmembrane domain {616-634}
cytoplasmic loop {635-653}
transmembrane domain {654-673}
MOTIF: leucine residue {654-660} (7)
exoplasmic loop {674-728}
transmembrane domain {729-753}
cytoplasmic loop {754-900}
MOTIF: glutamate residue {768-774} (7)
transmembrane domain {901-919}
exoplasmic loop {920-935}
transmembrane domain {936-955}
cytoplasmic loop {956-987}
transmembrane domain {988-1006}
exoplasmic loop {1007-1013}
transmembrane domain {1014-1032}
cytoplasmic loop {1033-1051}
transmembrane domain {1052-1071}
exoplasmic loop {1072-1161}
transmembrane domain {1162-1186}
MOTIF: isoleucine residue {1167-1173} (7)
cytoplasmic loop {1187-1239}
transmembrane domain {1240-1258}
exoplasmic loop {1259-1273}
transmembrane domain {1274-1293}
cytoplasmic loop {1294-1301}
transmembrane domain {1302-1320}
exoplasmic loop {1321-1372}
transmembrane domain {1373-1391}
cytoplasmic loop {1392-1410}
transmembrane domain {1411-1430}
exoplasmic loop {1431-1499}
MOTIF: N-glycosylation site {N1436}
N-glycosylation site {N1487}
transmembrane domain {1500-1524}
cytoplasmic domain {1525-2221}
MOTIF: Ser phosphorylation site {S1535}
Ca+2-binding site
SITE: 1553-1564
Ser phosphorylation site {S1973}
Ser phosphorylation site {S1981}
glycine-rich region {2084-2087}
Database Correlations
OMIM correlations
MORBIDMAP 114205
UniProt Q13936
PFAM correlations
Entrez Gene 775
Kegg hsa:775
References
- UniProt :accession Q13936
- GeneReviews
https://www.genecards.org/cgi-bin/carddisp.pl?gene=CACNA1C
- Cross-Disorder Group of the Psychiatric Genomics Consortium
Identification of risk loci with shared effects on five major
psychiatric disorders: a genome-wide analysis.
Lancet, Early Online Publication, 28 February 2013
PMID: 23453885
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)62129-1/abstract